Oncology Brothers: Practice-Changing Cancer Discussions

Managing Side Effects of HER2 Targeted Therapy - Zanidatamab & Trastuzumab deruxtecan (T-DXd)

May 8, 2025
Ask episode
Chapters
Transcript
Episode notes